WallStreetZenWallStreetZen

NASDAQ: AKBA
Akebia Therapeutics Inc Earnings & Revenue

AKBA past revenue growth

How has AKBA's revenue growth performed historically?
Company
-30.88%
Industry
90.19%
Market
19.07%
AKBA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AKBA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AKBA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AKBA earnings and revenue history

Current Revenue
$187.2M
Current Earnings
-$43.0M
Current Profit Margin
-23%

AKBA Return on Equity

Current Company
N/A
Current Industry
16.8%
Current Market
28.2%

Be the first to know when AKBA announces earnings.

AKBA Return on Assets

Current Company
-18%
Current Industry
3.2%
AKBA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AKBA Return on Capital Employed

Current Company
-22.68%
Current Industry
-42.4%
AKBA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AKBA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AKBA$187.23M$7.34M-$43.03M-4.40%N/A
OMER$0.00-$89.22M-$121.30M-100.00%N/A
PRLD$0.00-$122.31M-$125.55MN/AN/A
MGTX$697.00k-$46.76M-$74.11M-79.09%N/A
ADCT$68.62M-$135.32M-$227.23M+143.18%N/A

AKBA earnings dates

Next earnings date
Aug 23, 2024

Akebia Therapeutics Earnings & Revenue FAQ

What were AKBA's earnings last quarter?

On Invalid Date, Akebia Therapeutics (NASDAQ: AKBA) reported Q1 2024 earnings per share (EPS) of -$0.09, up 40% year over year. Total Akebia Therapeutics earnings for the quarter were -$17.99 million. In the same quarter last year, Akebia Therapeutics's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.

What was AKBA's earnings growth in the past year?

As of Q3 2024, Akebia Therapeutics's earnings has grown year over year. Akebia Therapeutics's earnings in the past year totalled -$43.03 million.

What is AKBA's earnings date?

Akebia Therapeutics's earnings date is Invalid Date. Add AKBA to your watchlist to be reminded of AKBA's next earnings announcement.

What was AKBA's revenue last quarter?

On Invalid Date, Akebia Therapeutics (NASDAQ: AKBA) reported Q1 2024 revenue of $32.61 million up 18.49% year over year. In the same quarter last year, Akebia Therapeutics's revenue was $40.01 million.

What was AKBA's revenue growth in the past year?

As of Q3 2024, Akebia Therapeutics's revenue has grown -30.88% year over year. This is 121.07 percentage points lower than the US Biotechnology industry revenue growth rate of 90.19%. Akebia Therapeutics's revenue in the past year totalled $187.23 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.